ESMO-Virtual-Advanced-Courses-advanced-badder-renal-cell-carcinoma-2022-1000x250-june

Start date: 20 Jun 2022
End date: 21 Jun 2022
Location: Virtual, GMT +8

Learning objectives

To understand essentials in the assessment and the value of multidisciplinary management of advanced bladder and renal cell carcinoma (RCC)
To learn about state-of-the-art advances in treatment of advanced bladder and renal cell carcinoma
To learn the principles of management of advanced bladder and renal cell carcinoma through direct exposure to real clinical scenarios

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Anja Lorch, Switzerland
Ravindran Kanesvaran, Singapore

Learning objectives

Accreditation

Co-Chairs

Supported by

You may also be interested in..